WHO/IAEA tackle investigational radiopharmaceutical GMP in draft guidance | RAPS: The revisions are coming as the use of radiopharmaceuticals to diagnose and treat cancers and other diseases is expanding rapidly; this growth “is accompanied by a set of challenges due to the complexity and unique nature of these agents.”
Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities
No comments:
Post a Comment